AIM
BIO icon

AIA Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

AIA Investment Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$45K Buy
88
+47
+115% +$23.8K 0.01% 320
2020
Q2 		$19K Buy
+41
New +$18.1K ﹤0.01% 346

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

AIA Investment Management's BIO Position: Q3 2020 in Review

AIA Investment Management increased its Bio-Rad Laboratories Class A (BIO) stake by 115% in Q3 2020, buying an estimated $23.8K and bringing the position to 88 shares worth $45K. The position accounts for 0.01% of the portfolio, ranked #320.

AIA Investment Management first reported a position in BIO in Q2 2020 and has held it in 2 quarters since. 478 funds tracked by Wall St. Rank hold BIO as of Q3 2020.

  • AIA Investment Management held 88 shares of Bio-Rad Laboratories Class A worth $45K as of Q3 2020.
  • AIA Investment Management bought 47 Bio-Rad Laboratories Class A shares in Q3 2020, an estimated $23.8K.
  • Bio-Rad Laboratories Class A made up 0.01% of AIA Investment Management's portfolio in Q3 2020, its #320 holding.
  • AIA Investment Management first reported a position in Bio-Rad Laboratories Class A in Q2 2020 and has held it in 2 quarters since.
  • 478 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2020.

Based on AIA Investment Management's 13F filing for Q3 2020, filed 16 Nov 2020.